Business Standard

MNCs, domestic drug makers did equally well in terms of growth rate

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

medicine
Premium

Representative Image

Sohini Das Mumbai
Home-grown drug makers enjoy 80 per cent share of the domestic market and take the lion’s share when it comes to brand launches. The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate. 

According to the data from market research firm AIOCD AWACS, the moving annual turnover growth for November 2019 (which represents the last 12 months) for Indian firms is 9.9 per cent, while for multinational drug firms, it is at 9.7 per cent. During this period, the overall pharma market grew by 9.8 per

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 30 2019 | 11:02 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com